Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
06/28/2012 | CA2822216A1 Means and method for predicting diabetes |
06/28/2012 | CA2821907A1 Method for measuring breath alcohol concentration and apparatus therefor |
06/28/2012 | CA2821904A1 A method of differentiating oncogenic changes of the thyroid, a kit to embody the method and the use of metallothionein (mt) for differentiating oncogenic changes of the thyroid |
06/28/2012 | CA2821673A1 Methods of detecting leukemia/ lymphoma and induction of the same |
06/28/2012 | CA2821651A1 Biomarkers |
06/28/2012 | CA2821406A1 Biomarkers |
06/28/2012 | CA2820344A1 Method to characterize underground formation |
06/28/2012 | CA2817928A1 Detection of a posttranslationally modified polypeptide by a bi-valent binding agent |
06/28/2012 | CA2817519A1 Bin1 expression as a marker of skeletal muscle mass and neurological conditions |
06/28/2012 | CA2817455A1 Detection of a polypeptide dimer by a bivalent binding agent |
06/27/2012 | EP2469886A2 Device for monitoring at least a physical characteristic of a building material |
06/27/2012 | EP2469439A2 Systems and methods for detecting biological features |
06/27/2012 | EP2469285A1 Water soluble metal and semiconductor nanoparticle complexes |
06/27/2012 | EP2469284A1 Diagnosis and monitoring of chronic renal disease using NGAL |
06/27/2012 | EP2469283A1 Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker. |
06/27/2012 | EP2469282A1 Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers |
06/27/2012 | EP2469281A1 Method for managing the risk of liver injury in patients receiving treatment with dronedarone |
06/27/2012 | EP2469280A1 Method for managing the risk of liver injury in patients receiving treatment with dronedarone |
06/27/2012 | EP2469279A1 Cystatin C, lysozyme and beta-2-microglobulin as biomarker for peripheral artery disease |
06/27/2012 | EP2469278A1 Reagentless fluorescent biosensors from nanofitins, rational design methods to create reagentless fluorescent biosensors and methods of their use |
06/27/2012 | EP2469277A1 Method for employing sec-ftir data to predict mechanical properties of polyethylene |
06/27/2012 | EP2469275A1 Cantilevered carbon dioxide sensor |
06/27/2012 | EP2469273A1 Method and device for detecting malfunctions of process water strippers |
06/27/2012 | EP2469272A1 Acid/Base Sensor |
06/27/2012 | EP2469269A1 Assay device with shared zones |
06/27/2012 | EP2469267A2 Analyzer system and method for multivariate characterization of properties in crude and heavy hydrocarbon oils |
06/27/2012 | EP2468899A2 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
06/27/2012 | EP2468897A2 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
06/27/2012 | EP2468896A2 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
06/27/2012 | EP2468895A2 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
06/27/2012 | EP2468894A2 MicroRNA-based Methods and Compositions for the Diagnosis and Treatment of Solid Cancers |
06/27/2012 | EP2468893A2 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
06/27/2012 | EP2468892A2 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
06/27/2012 | EP2468890A2 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
06/27/2012 | EP2468882A1 Aurora kinase polypeptides for identifying fungicidal compounds |
06/27/2012 | EP2468863A1 Therapeutic peptides |
06/27/2012 | EP2468767A2 Structure of the insulin receptor ectodomain |
06/27/2012 | EP2468766A2 Structure of the insulin receptor ectodomain |
06/27/2012 | EP2468734A1 Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry |
06/27/2012 | EP2468178A1 Integrated test element for one-off holding and analysis of a sample to be tested |
06/27/2012 | EP2467724A2 Survival prognostic assay |
06/27/2012 | EP2467723A1 A method of predicting response to thalidomide in multiple myeloma patients |
06/27/2012 | EP2467722A1 Detection of different target components by cluster formation |
06/27/2012 | EP2467721A1 Test system for visual analysis |
06/27/2012 | EP2467720A1 Methods and compositions for diagnosis of acute myocardial infarction (ami) |
06/27/2012 | EP2467719A2 Marker detection for characterizing the risk of cardiovascular disease or complications thereof |
06/27/2012 | EP2467718A1 Fluid specimen collection device |
06/27/2012 | EP2467717A1 Simplified magazining of integrated systems |
06/27/2012 | EP2467716A1 Identification and quantification of biomarkers for evaluating the risk of preterm birth |
06/27/2012 | EP2467715A1 Riboflavin based aerosol and use as placebo in trials |
06/27/2012 | EP2467714A1 In vitro screening assays |
06/27/2012 | EP2467707A2 Apparatus and method for measuring biochemical parameters |
06/27/2012 | EP2467706A1 Methods and systems for the quantitative chemical speciation of heavy metals and other toxic pollutants |
06/27/2012 | EP2467499A1 Cstf2 for target genes of lung cancer therapy and diagnosis |
06/27/2012 | EP2467495A2 Diagnosing and managing venous thromboembolism and intracardiac thrombi using a provoked d-dimer test |
06/27/2012 | EP2467494A1 Pon1 as a marker for heart failure |
06/27/2012 | EP2467491A1 Methods of using cd44 fusion proteins to treat cancer |
06/27/2012 | EP2467486A2 Heavy metal remediation system |
06/27/2012 | EP2467485A1 Screening of protein candidates |
06/27/2012 | EP2467484A2 Porcine torque teno virus vaccines and diagnosis |
06/27/2012 | EP2467483A1 Dna ligands for aflatoxin and zearalenone |
06/27/2012 | EP2467468A1 Human skin explant culture system and use therefor |
06/27/2012 | EP2467402A1 Anti-cmet antibody and its use for the detection and the diagnosis of cancer |
06/27/2012 | EP2467161A1 Methods for diagnosing diabetes and determining effectiveness of treatments |
06/27/2012 | EP2467159A1 Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy |
06/27/2012 | EP2467140A2 Method of threating cancer |
06/27/2012 | EP2467138A1 Use of aerosolized antibiotics for treating chronic obstructive pulmonary disease |
06/27/2012 | EP2140247B1 Method for modulating activity of t lymphocytes |
06/27/2012 | EP2086996B1 Marker specific for an oxidative degradation of tissues containing type iii collagen, means, methods and kits for the diagnosis, monitoring or prognosis of pathologies targeted by said marker |
06/27/2012 | EP2010922B1 Methods for endometriosis screening |
06/27/2012 | EP2010917B1 Melanoma biomarker and methods of uses |
06/27/2012 | EP1996923B1 Methods for distinguishing isomers using mass spectrometry |
06/27/2012 | EP1988163B1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
06/27/2012 | EP1982183B1 Dry stick device and method for determining an analyte in a sample |
06/27/2012 | EP1976987B1 Cancer-associated Scratch variant |
06/27/2012 | EP1945809B1 Quantification of microsphere suspension hybridization and uses thereof |
06/27/2012 | EP1883811B1 An integrated on-line two-dimensional method and device for synchronized analytical temperature rising elution fractionation and gel permeation chromatography |
06/27/2012 | EP1765065B1 Methods and compositions related to delivery of chemical compounds to invertebrate embryos |
06/27/2012 | EP1673459B1 Luciferase biosensor |
06/27/2012 | EP1576059B1 Carboxamide-substituted dyes for analytical applications |
06/27/2012 | EP1147187B1 Process for the detection of an endogenous nucleic acid fragment associated with an autoimmune disease |
06/27/2012 | EP1034277B1 Extracellular matrix-binding proteins from Staphylococcus aureus |
06/27/2012 | CN202285020U 一种全自动反应仪的载物平台 A fully automatic reaction instrument carrier platform |
06/27/2012 | CN202285017U 甲烷在线监测分析仪 Methane online monitoring analyzers |
06/27/2012 | CN202285016U 防护陶瓷环的氧传感器 Oxygen sensor protection ceramic ring |
06/27/2012 | CN202285015U 气体检测用零排放装置 Gas detection device zero emissions |
06/27/2012 | CN202285014U 煤矿灾区环境远距离侦测系统 Mine disaster area environmental remote detection system |
06/27/2012 | CN202284201U Rapid extraction instrument of trace volatile oil of ground openings |
06/27/2012 | CN1989411B Diagnostic and screening methods and kits associated with proteolytic activity |
06/27/2012 | CN1979163B Immunoassay product and process |
06/27/2012 | CN1906295B Variable valve apparatus and methods |
06/27/2012 | CN1902490B Method of detecting biological molecules, and labeling dye and labeling kit used for the same |
06/27/2012 | CN1842707B Prion protein binding materials and methods of use |
06/27/2012 | CN1662817B Marker for measuring liver cirrhosis |
06/27/2012 | CN102521519A Method and system for predicting storage life of liquid oil product |
06/27/2012 | CN102520447A Oil bright point identification system |
06/27/2012 | CN102520198A Ethanol concentration detection kit and manufacture method thereof |
06/27/2012 | CN102520197A Prostaglandin F2 Alpha enzyme-linked immunoassays kit |
06/27/2012 | CN102520196A Neonatus thyroid stimulating hormone/free thyroxine double-tagging detection kit and corresponding detection method |
06/27/2012 | CN102520195A Chromogranin A chemiluminescence immunoassay reagent kit and preparation method thereof |